Atazanavir Sulfate; Cobicistat Tablet shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting Nov 3, 2025 · last update Nov 3, 2025
Manufacturers: Bristol Myers Squibb Co.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Evotaz, Tablet, 300 mg; 150 mg (NDC 0003-3641-11) | Bristol Myers Squibb Co. | To Be Discontinued | — | The global Cease Manufacture date for EVOTAZ® currently is estimated to begin April 2026. | Posted Nov 3, 2025 Updated Nov 3, 2025 Discontinued Nov 3, 2025 |